AAAAAA

   
Results: 1-12 |
Results: 12
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH EARLY-PHASE HEMATOLOGIC MALIGNANCY - A RETROSPECTIVE COMPARISON OF SHORT-TERM OUTCOME WITH BONE-MARROW TRANSPLANTATION
Authors: LEMOLI RM BANDINI G LEOPARDI G ROSTI G BONINI A FORTUNA A RONDELLI D MANGIANTI S MOTTA MR RIZZI S TASSI C CAVO M REMIDDI C CURTI A CONTE R TURA S
Citation: Rm. Lemoli et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH EARLY-PHASE HEMATOLOGIC MALIGNANCY - A RETROSPECTIVE COMPARISON OF SHORT-TERM OUTCOME WITH BONE-MARROW TRANSPLANTATION, Haematologica, 83(1), 1998, pp. 48-55
BIG BU CY IS ASSOCIATED WITH A FAVORABLE LONG-TERM OUTCOME IN PATIENTS ALLOTRANSPLANTED FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE/
Authors: BONINI A BANDINI G ROSTI G RONDELLI D TESTONI N REMIDDI C MOTTA MR RIZZI S MANGIANTI S CAMPANINI E ZUFFA E TURA S
Citation: A. Bonini et al., BIG BU CY IS ASSOCIATED WITH A FAVORABLE LONG-TERM OUTCOME IN PATIENTS ALLOTRANSPLANTED FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE/, Bone marrow transplantation, 21(11), 1998, pp. 1085-1089
PHARMACOLOGICAL PURGING OF PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS OF HIGH-RISK ACUTE-LEUKEMIA PATIENTS - PRECLINICAL AND CLINICAL-STUDIES
Authors: MOTTA MR LEOPARDI G RIZZI S MANGIANTI S VISANI G CAMPANINI E TURA S LEMOLI RM
Citation: Mr. Motta et al., PHARMACOLOGICAL PURGING OF PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS OF HIGH-RISK ACUTE-LEUKEMIA PATIENTS - PRECLINICAL AND CLINICAL-STUDIES, Bone marrow transplantation, 21, 1998, pp. 22-22
NO SIGNIFICANT DIFFERENCE BETWEEN PBSCT AND ABMT PERFORMED AFTER THE SAME INDUCTION CONSOLIDATION - A STUDY ON 92 CONSECUTIVE ACUTE MYELOID-LEUKEMIA PATIENTS WITH A MEAN FOLLOW-UP OF 21 MONTHS/
Authors: VISANI G LEMOLI RM PELLACANI A TOSI P TESTONI N MOTTA MR RIZZI S MANGIANTI S MARINELLI G PASTANO R DIZDARI A TURA S
Citation: G. Visani et al., NO SIGNIFICANT DIFFERENCE BETWEEN PBSCT AND ABMT PERFORMED AFTER THE SAME INDUCTION CONSOLIDATION - A STUDY ON 92 CONSECUTIVE ACUTE MYELOID-LEUKEMIA PATIENTS WITH A MEAN FOLLOW-UP OF 21 MONTHS/, Bone marrow transplantation, 21, 1998, pp. 41-41
A POLICY OF WAIT AND SEE FOR CYTOMEGALOVIRUS ANTIGEMIA POSITIVITY (CMV AG-MARROW TRANSPLANTATION (BMT)() AFTER ALLOGENEIC BONE)
Authors: STANZANI M BANDINI B ROSTI G LEOPARDI G REMIDDI C BONINI A MANGIANTI S TURA S
Citation: M. Stanzani et al., A POLICY OF WAIT AND SEE FOR CYTOMEGALOVIRUS ANTIGEMIA POSITIVITY (CMV AG-MARROW TRANSPLANTATION (BMT)() AFTER ALLOGENEIC BONE), Bone marrow transplantation, 21, 1998, pp. 491-491
DOUBLE AUTOTRANSPLANTATION OF PURIFIED HEMATOPOIETIC CD34-MYELOMA (MM) PATIENTS( CELLS IN MULTIPLE)
Authors: LEMOLI RM LEOPARDI G CAVO M MOTTA MR RIZZI S BENNI M MANGIANTI S CAMPANINI E TURA S
Citation: Rm. Lemoli et al., DOUBLE AUTOTRANSPLANTATION OF PURIFIED HEMATOPOIETIC CD34-MYELOMA (MM) PATIENTS( CELLS IN MULTIPLE), Bone marrow transplantation, 21, 1998, pp. 730-730
SEQUENTIAL POSITIVE NEGATIVE SELECTION AND TRANSPLANTATION OF CD34+ B-LIN-NEGATIVE CELLS IN MULTIPLE-MYELOMA (MM) PATIENTS/
Authors: RIZZI S MOTTA MR MANGIANTI S FORTUNA A TERRAGNA C CAVO M CAMPANINI E MARTINELLI G OMBROSI L OLIVIERI A LEONI P TURA S LEMOLI RM
Citation: S. Rizzi et al., SEQUENTIAL POSITIVE NEGATIVE SELECTION AND TRANSPLANTATION OF CD34+ B-LIN-NEGATIVE CELLS IN MULTIPLE-MYELOMA (MM) PATIENTS/, Bone marrow transplantation, 21, 1998, pp. 731-731
MEGAKARYOCYTE PROGENITORS DERIVED FROM BONE-MARROW OR G-CSF-MOBILIZEDPERIPHERAL-BLOOD CD34(-3 (IL-3) AND PEG-RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)() CELLS SHOW A DISTINCTPHENOTYPE AND RESPONSIVENESS TO INTERLEUKIN)
Authors: CATANI L GUGLIOTTA L CAMPANINI E MANGIANTI S GIBELLINI D BARAVELLI S VIANELLI N LEMOLI RM TURA S
Citation: L. Catani et al., MEGAKARYOCYTE PROGENITORS DERIVED FROM BONE-MARROW OR G-CSF-MOBILIZEDPERIPHERAL-BLOOD CD34(-3 (IL-3) AND PEG-RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)() CELLS SHOW A DISTINCTPHENOTYPE AND RESPONSIVENESS TO INTERLEUKIN), British Journal of Haematology, 100(1), 1998, pp. 207-218
PHARMACOLOGICAL PURGING OF MINIMAL RESIDUAL DISEASE FROM PERIPHERAL-BLOOD STEM-CELL COLLECTIONS OF ACUTE MYELOBLASTIC-LEUKEMIA PATIENTS - PRECLINICAL STUDIES
Authors: MOTTA MR MANGIANTI S RIZZI S RATTA M CAMPANINI E FORTUNA A FOGLI M TURA S LEMOLI RM
Citation: Mr. Motta et al., PHARMACOLOGICAL PURGING OF MINIMAL RESIDUAL DISEASE FROM PERIPHERAL-BLOOD STEM-CELL COLLECTIONS OF ACUTE MYELOBLASTIC-LEUKEMIA PATIENTS - PRECLINICAL STUDIES, Experimental hematology, 25(12), 1997, pp. 1261-1269
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LATE FIRST COMPLETE REMISSION IMPROVES OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA
Authors: MIGGIANO MC GHERLINZONI F ROSTI G BANDINI G VISANI G FIACCHINI M RICCI P TESTONI N MOTTA MR GEROMIN A RIZZI S BELARDINELLI A MANGIANTI S MANFROI S TURA S
Citation: Mc. Miggiano et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LATE FIRST COMPLETE REMISSION IMPROVES OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA, Leukemia, 10(3), 1996, pp. 402-409
DETECTION OF OCCASIONAL AND CLONAL CHROMOSOME-ABERRATIONS IN PATIENTSWITH ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: TESTONI N MARTINELLI G ZACCARIA A MIGGIANO MC PELLICONI S VISANI G MANFROI S GHERLINZONI F MANGIANTI S TURA S
Citation: N. Testoni et al., DETECTION OF OCCASIONAL AND CLONAL CHROMOSOME-ABERRATIONS IN PATIENTSWITH ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1141-1145
CONCOMITANT MOBILIZATION OF PLASMA-CELLS AND HEMATOPOIETIC PROGENITORS INTO PERIPHERAL-BLOOD OF MULTIPLE-MYELOMA PATIENTS - POSITIVE SELECTION AND TRANSPLANTATION OF ENRICHED CD34(-CELLS() CELLS TO REMOVE CIRCULATING TUMOR)
Authors: LEMOLI RM FORTUNA A MOTTA MR RIZZI S GIUDICE V NANNETTI A MARTINELLI G CAVO M AMABILE M MANGIANTI S FOGLI M CONTE R TURA S
Citation: Rm. Lemoli et al., CONCOMITANT MOBILIZATION OF PLASMA-CELLS AND HEMATOPOIETIC PROGENITORS INTO PERIPHERAL-BLOOD OF MULTIPLE-MYELOMA PATIENTS - POSITIVE SELECTION AND TRANSPLANTATION OF ENRICHED CD34(-CELLS() CELLS TO REMOVE CIRCULATING TUMOR), Blood, 87(4), 1996, pp. 1625-1634
Risultati: 1-12 |